Revolution Medicines, Inc. (RVMD)
149.12
+4.93
(+3.42%)
USD |
NASDAQ |
Jun 11, 13:37
Revolution Medicines Accounts Payable (Quarterly) : 80.54M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 80.54M |
| December 31, 2025 | 64.62M |
| September 30, 2025 | 74.85M |
| June 30, 2025 | 56.76M |
| March 31, 2025 | 47.51M |
| December 31, 2024 | 54.43M |
| September 30, 2024 | 24.46M |
| June 30, 2024 | 29.32M |
| March 31, 2024 | 32.38M |
| December 31, 2023 | 61.79M |
| September 30, 2023 | 29.63M |
| June 30, 2023 | 29.78M |
| March 31, 2023 | 19.91M |
| December 31, 2022 | 21.31M |
| September 30, 2022 | 24.38M |
| Date | Value |
|---|---|
| June 30, 2022 | 14.07M |
| March 31, 2022 | 14.17M |
| December 31, 2021 | 14.06M |
| September 30, 2021 | 10.49M |
| June 30, 2021 | 10.44M |
| March 31, 2021 | 9.65M |
| December 31, 2020 | 12.61M |
| September 30, 2020 | 6.656M |
| June 30, 2020 | 10.17M |
| March 31, 2020 | 7.877M |
| December 31, 2019 | 11.40M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 5.236M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Erasca, Inc. | 2.163M |
| Tango Therapeutics, Inc. | 2.43M |
| Kymera Therapeutics, Inc. | 12.84M |
| Replimune Group, Inc. | 5.647M |
| Arrowhead Pharmaceuticals, Inc. | 30.75M |